RevealAI-Lung

Malignancy Scoring for Lung Nodules
- – Reduce unnecessary procedures and detect lung cancer up to one year sooner with RevalAI-Lung malignancy scoring from RevealDx.
– Compares selected nodules against a clinical database of nodules with known outcomes to assist clinicians’ assessment of patients’ cancer risk.
- – Proven to reduce false positives and flag at-risk patients sooner:
18% reduction in false positives*
45% increase in early diagnosis possible*
*Adams, Scott J et al., JACR September 2022
Because of malignancy scoring’s health economics benefits (e.g. reduced unnecessary procedures), it stands as the first and only radiology AI to be reimbursed in Europe, starting in Germany. Read all about this game-changing development here.